Given that the increase in eIF4E phosphorylation might counteract rapamycin’s inhibitory effect on translation initiation25, we hypothesized that co-targeting AKT-mTOR and Mnk-eIF4E signaling would result in augmented growth-inhibitory effects in cancer cells. Here, AKT1 is linked to cancer.